Clinical trial
Prostate Adenocarcinoma TransCutaneous Hormones
NCT00303784 · University College, London, Other · Unknown status
Key facts
| NCT number | NCT00303784 |
|---|---|
| Title | Prostate Adenocarcinoma TransCutaneous Hormones |
| Official title | A Randomized-Controlled Trial of Transcutaneous Oestrogen Patches Versus LHRH Agonists in Prostate Cancer |
| Acronym | PATCH |
| Lead sponsor | University College, London, Other |
| Collaborators | Medical Research Council |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Cardiovascular Complications, Hot Flashes, Osteoporosis, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Goserelin, Estradiol |
| Enrollment | 2,200 |
| Start date | Mar 1, 2006 |
| Primary completion | Aug 1, 2021 |
| Completion | Aug 1, 2021 |
| First posted | Mar 17, 2006 |
| Last update posted | Nov 27, 2020 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: